Trevena Stock (NASDAQ: TRVN) stock price, news, charts, stock research, profile.
Open | $0.440 |
Close | $0.440 |
Volume / Avg. | 118.422K / 205.355K |
Day Range | 0.401 - 0.450 |
52 Wk Range | 0.300 - 3.280 |
Market Cap | $7.513M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 0.33% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Trevena (NASDAQ: TRVN) through any online brokerage.
Other companies in Trevena’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Addex Therapeutics (NASDAQ:ADXN), NuCana (NASDAQ:NCNA) and Galera Therapeutics (NASDAQ:GRTX).
The latest price target for Trevena (NASDAQ: TRVN) was reported by HC Wainwright & Co. on Tuesday, April 2, 2024. The analyst firm set a price target for 9.00 expecting TRVN to rise to within 12 months (a possible 2094.59% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Trevena (NASDAQ: TRVN) is $0.4101 last updated May 7, 2024 at 6:57 PM EDT.
There are no upcoming dividends for Trevena.
Trevena’s Q1 earnings are confirmed for Tuesday, May 21, 2024.
There is no upcoming split for Trevena.
Trevena is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.